Mei-Chih Chen

8PUBLICATIONS
13CO-AUTHORS
Medical devicesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAquaculture and fisheries stock assessmentPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 13, 2025
Engineering HLA-G-targeted extracellular vesicles nanoplatform for enhanced cancer therapy through precise cancer drug delivery.

Ming-You Shie, Shi-Wei Huang, Yeh Chen

|Sep 05, 2024
Targeting Dual Immune Checkpoints PD-L1 and HLA-G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer.

Yu-Chuan Lin, Mei-Chih Chen, Shi-Wei Huang

|Apr 29, 2024
Metformin inhibits nerve growth factor-induced sympathetic neuron differentiation through p35/CDK5 inhibition.

Muhammet Oner, Mei-Chih Chen, Pang-Ting Cheng

|Sep 25, 2023
RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells.

Wan-Ling Liao, Ho Lin, Yu-Hsuan Li

|Apr 05, 2023
Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer.

Mei-Chih Chen, Meng-Yu Hung, Chih-Ming Pan

|Mar 28, 2023
The involvement of Aurora-A and p53 in oxaliplatin-resistant colon cancer cells.

Mei-Chih Chen, Bing-Ze Yang, Wei-Wen Kuo

Pageof 2

Frequent Collaborators

3 joint publications

Ho Lin

2 joint publications

Chih-Yang Huang

2 joint publications

Muhammet Oner

1 joint publications

Wei-Wen Kuo